P-175. Clinical Profile and Management Outcomes of Isolated Myocysticercosis: A Prospective Observational Cohort Study from a Tertiary Care Center in India

Abstract Background Cysticercosis, caused by Taenia solium larvae, remains endemic in Asia and Latin America. Isolated myocysticercosis—confined to skeletal muscle—is uncommon and often misdiagnosed due to nonspecific symptoms. In India, data on isolated muscular involvement is limited, usually restricted to case reports. Methods This prospective observational study was conducted at a North Indian tertiary center (Jan 2022–July 2024). Patients with muscular swellings diagnosed as myocysticercosis via clinical, radiological (USG/MRI), and/or histopathological criteria were enrolled after informed consent. Inclusion: Isolated muscular involvement without CNS lesions. Exclusion: Neurocysticercosis or inadequate follow-up (< 1 month). Patients were monitored for clinical/radiological resolution, complications, and relapse. Results Fourteen patients (7 males, 7 females), mean age 36.1 years, were included. Most (86%) presented with swelling; others had pain (3) or fever (1). Thirteen had solitary lesions; commonly involved muscles were biceps (3), masseter (2), external oblique (2). Ten patients (71%) were vegetarians. Nine (64%) had no comorbidities; others had diabetes (3), migraine (1), or thyroid swelling (1). All underwent fundoscopy and brain/orbit imaging to exclude neuro/ocular cysticercosis. Albendazole was used in all; three received combination therapy (with praziquantel or steroids). Median treatment duration was 3.5 weeks. Resolution with calcification occurred in 9 patients (64%). None required surgery or showed relapse over ≥6 months of follow-up. Conclusion Isolated myocysticercosis presents as localized muscular swelling, affects diverse muscles, and occurs regardless of diet. Albendazole-based therapy is effective. This study highlights the clinical spectrum, muscle involvement, and non-surgical resolution, underscoring the need for standardized management protocols and multicenter data. Disclosures All Authors: No reported disclosures

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.399
Primary Topic
Parasitic infections in humans and animals
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-175. Clinical Profile and Management Outcomes of Isolated Myocysticercosis: A Prospective Observational Cohort Study from a Tertiary Care Center in India

Sayan Maharatna, Stanzin Spalkit, Charu Rajoria, M Soneja et al.
Open Forum Infectious Diseases
Parasitic infections in humans and animals
article

P-175. Clinical Profile and Management Outcomes of Isolated Myocysticercosis: A Prospective Observational Cohort Study from a Tertiary Care Center in India

Sayan Maharatna, Stanzin Spalkit, Charu Rajoria, M Soneja, Baidhnath Kumar Gupta, Insha Insha, Satish Swain
article en

Abstract

Abstract Background Cysticercosis, caused by Taenia solium larvae, remains endemic in Asia and Latin America. Isolated myocysticercosis—confined to skeletal muscle—is uncommon and often misdiagnosed due to nonspecific symptoms. In India, data on isolated muscular involvement is limited, usually restricted to case reports. Methods This prospective observational study was conducted at a North Indian tertiary center (Jan 2022–July 2024). Patients with muscular swellings diagnosed as myocysticercosis via clinical, radiological (USG/MRI), and/or histopathological criteria were enrolled after informed consent. Inclusion: Isolated muscular involvement without CNS lesions. Exclusion: Neurocysticercosis or inadequate follow-up (< 1 month). Patients were monitored for clinical/radiological resolution, complications, and relapse. Results Fourteen patients (7 males, 7 females), mean age 36.1 years, were included. Most (86%) presented with swelling; others had pain (3) or fever (1). Thirteen had solitary lesions; commonly involved muscles were biceps (3), masseter (2), external oblique (2). Ten patients (71%) were vegetarians. Nine (64%) had no comorbidities; others had diabetes (3), migraine (1), or thyroid swelling (1). All underwent fundoscopy and brain/orbit imaging to exclude neuro/ocular cysticercosis. Albendazole was used in all; three received combination therapy (with praziquantel or steroids). Median treatment duration was 3.5 weeks. Resolution with calcification occurred in 9 patients (64%). None required surgery or showed relapse over ≥6 months of follow-up. Conclusion Isolated myocysticercosis presents as localized muscular swelling, affects diverse muscles, and occurs regardless of diet. Albendazole-based therapy is effective. This study highlights the clinical spectrum, muscle involvement, and non-surgical resolution, underscoring the need for standardized management protocols and multicenter data. Disclosures All Authors: No reported disclosures

Open Forum Infectious DiseasesVol. 13(Supplement_1)
All India Institute of Medical Sciences (IN)
Openalex Percentile: Top 91%
Parasitic infections in humans and animals
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.